Breast Cancer | Specialty

The OncLive Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

ESMO 2019: Dr. Bekaii-Saab Highlights Important Trials in GI Malignancies

September 29th 2019

ESMO 2019: Dr. Mirza on Important Trials with PARP Inhibitors in Ovarian Cancer

September 29th 2019

ESMO 2019: Dr. McGregor Highlights Impactful 2019 Prostate Cancer Studies

September 29th 2019

ESMO 2019: Dr. Spigel Highlights Progress in Lung Cancer

September 29th 2019

ESMO 2019: Dr. Rugo Highlights Progress in Breast Cancer

September 29th 2019

ESMO 2019: Dr. O'Shaughnessy Highlights Progress in Breast Cancer

September 29th 2019

ESMO 2019: Dr. Choueiri Discusses Novel Treatment Strategies in GU Cancers

September 29th 2019

ESMO 2019: Dr. Hamid Discusses Exciting Immunotherapy Data in Melanoma

September 29th 2019

ESMO 2019: Dr. Ramalingam Discusses Confirmatory Data in Advanced NSCLC

September 29th 2019

OncLive News Network On Location: ESMO 2019 Day 3

September 29th 2019

OncLive News Network On Location: ESMO 2019 Day 2

September 29th 2019

OncLive News Network On Location: ESMO 2019 Day 1

September 29th 2019

Adding Atezolizumab May Improve Outcomes in HER2+ Breast Cancer With PD-L1 Expression

September 28th 2019

A numerical improvement in overall survival was realized with the addition of atezolizumab (Tecentriq) to ado-trastuzumab emtansine (T-DM1; Kadcyla) compared with T-DM1 alone.

CDK4/6 Inhibitors Continue to Change Practice in HR+ Breast Cancer

September 27th 2019

Sarah Sammons, MD, discussed the MONALEESA-7 and MONARCH 2 studies and how CDK4/6 inhibitors are changing the advanced hormone receptor–positive, HER2-negative breast cancer space.

Workplace Accommodations Would Ease the Burden for Patients With Cancer

September 26th 2019

Women with breast cancer who have lower incomes and are members of minority populations are less likely to return to work following surgery and chemotherapy, and oncologists need to help them obtain workplace accommodations to ease their return to employment.

Expert Emphasizes Exercise to Minimize Cardiac Toxicity in Breast Cancer

September 26th 2019

Susan Faye Dent, MD, discussed the importance of cardiac health in patients with breast cancer.

Broader Trial Eligibility Criteria Expands Options for Brain Mets in Breast Cancer

September 26th 2019

Carey K. Anders, MD, discussed current approaches in the management of patients with breast cancer that has metastasized to the brain.

Immunotherapy Begins New Therapeutic Path in Metastatic TNBC

September 25th 2019

Jeremy M. Force, DO, discussed current and emerging immunotherapy options and ongoing challenges in metastatic triple-negative breast cancer.

Dr. Goetz on Adverse Events With Aromatase Inhibitors in Breast Cancer

September 25th 2019

Matthew P. Goetz, MD, discusses adverse events associated with aromatase inhibitors.

Genomics Are Key to Unlocking Breast Cancer Biology

September 23rd 2019

Paul Kelly Marcom, MD, discusses the role of genomic testing in breast cancer.